Akoya Biosciences, Inc. (AKYA)
USD 2.45
(-3.54%)
USD 2.45
(-3.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 85.7 Million USD | 13.09% |
| 2022 | 75.78 Million USD | 133.39% |
| 2021 | 32.47 Million USD | -7.21% |
| 2020 | 34.99 Million USD | 41.38% |
| 2019 | 24.75 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 85.18 Million USD | -0.6% |
| 2024 Q2 | 84.69 Million USD | -0.58% |
| 2023 Q1 | 75.27 Million USD | -0.67% |
| 2023 FY | 85.7 Million USD | 13.09% |
| 2023 Q3 | 75.07 Million USD | -0.79% |
| 2023 Q2 | 75.67 Million USD | 0.53% |
| 2023 Q4 | 85.7 Million USD | 14.16% |
| 2022 Q2 | 55.94 Million USD | 27.97% |
| 2022 Q1 | 43.71 Million USD | 34.64% |
| 2022 Q4 | 75.78 Million USD | 15.3% |
| 2022 FY | 75.78 Million USD | 133.39% |
| 2022 Q3 | 65.72 Million USD | 17.48% |
| 2021 Q4 | 32.47 Million USD | -1.32% |
| 2021 Q2 | 32.87 Million USD | -6.89% |
| 2021 Q1 | 35.3 Million USD | 0.88% |
| 2021 FY | 32.47 Million USD | -7.21% |
| 2021 Q3 | 32.9 Million USD | 0.1% |
| 2020 Q4 | 34.99 Million USD | 0.0% |
| 2020 FY | 34.99 Million USD | 41.38% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 24.75 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AngioDynamics, Inc. | 5.91 Million USD | -1349.205% |
| AtriCure, Inc. | 74.49 Million USD | -15.051% |
| Avinger, Inc. | 15.39 Million USD | -456.713% |
| Azenta, Inc. | 60.43 Million USD | -41.813% |
| BioLife Solutions, Inc. | 42.69 Million USD | -100.759% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 96.664% |
| Daxor Corporation | 755.65 Thousand USD | -11241.888% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -1095.675% |
| Femasys Inc. | 6.7 Million USD | -1179.026% |
| GlucoTrack, Inc. | 196 Thousand USD | -43627.551% |
| Harvard Bioscience, Inc. | 42.77 Million USD | -100.374% |
| Hologic, Inc. | 2.53 Billion USD | 96.619% |
| ICU Medical, Inc. | 1.7 Billion USD | 94.972% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 4.559% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -1828.092% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | -348.84% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 91.164% |
| Microbot Medical Inc. | 231 Thousand USD | -37002.165% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -1069.069% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 90.385% |
| Nephros, Inc. | 1.83 Million USD | -4568.083% |
| NovoCure Limited | 596.24 Million USD | 85.626% |
| NEXGEL, Inc. | 2.79 Million USD | -2963.117% |
| NEXGEL, Inc. | 2.79 Million USD | -2963.117% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | -13.838% |
| OraSure Technologies, Inc. | 13.5 Million USD | -534.671% |
| Pro-Dex, Inc. | 13.54 Million USD | -532.657% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -837.292% |
| Predictive Oncology Inc. | 2.85 Million USD | -2900.055% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -2395.472% |
| QuidelOrtho Corporation | 2.61 Billion USD | 96.721% |
| Repligen Corporation | 711.8 Million USD | 87.959% |
| Sanara MedTech Inc. | 11.79 Million USD | -626.808% |
| STAAR Surgical Company | 35.83 Million USD | -139.175% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -24960.234% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 96.272% |
| Jin Medical International Ltd. | 4.11 Million USD | -1983.783% |